Company Overview
About Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Business Model & Competitive Advantage
Pfizer's core commercial portfolio extends across oncology, rare disease, internal medicine, and vaccines. Eliquis (apixaban, co-promoted with Bristol-Myers Squibb) remains the world's best-selling anticoagulant; Ibrance leads in CDK4/6 inhibitor breast cancer therapy; Vyndaqel/Vyndamax dominates the ATTR-CM (transthyretin cardiomyopathy) market where it has achieved blockbuster status. The Prevnar pneumococcal vaccine franchise and Nimenrix meningococcal vaccines anchor a diversified global vaccine portfolio. Pfizer's "Fit-to-Win" restructuring program targets $4 billion in annual cost savings by 2025, realigning R&D investments toward the highest-value pipeline opportunities post-Seagen integration.
Competitive Landscape 2025–2026
In 2025-2026, Pfizer confronts significant patent cliff risks: Eliquis faces generic competition beginning in 2026-2028, representing roughly $7 billion in annual U.S. revenues at risk. The Seagen ADC platform is the primary offense against this cliff, with Padcev already generating $1 billion-plus in annual revenues for metastatic urothelial cancer. Competitive pressures come from AstraZeneca (Enhertu in ADCs), Eli Lilly (oncology expansion), and Merck (Keytruda franchise). Activist investor Starboard Value took a stake in late 2024 and has pressed for more aggressive cost cuts and strategic review. Pfizer's GLP-1 obesity drug danuglipron failed Phase 2 trials in 2023, leaving the company without a direct entry in the fast-growing obesity therapeutics market dominated by Eli Lilly and Novo Nordisk.
The Pfizer Story
Founders
Company Timeline
Major milestones in Pfizer's journey
Leadership Team
Meet the leaders behind Pfizer
Dr. Albert Bourla
Albert Bourla is a Greek-American veterinarian and businessman who became CEO of Pfizer in January 2019 and Chairman in February 2019. During his 30+ years at Pfizer, he held senior management positions across five countries and established Pfizer's Purpose Blueprint with core values of Courage, Excellence, Equity, and Joy to create a culture where science and people thrive.
David M. Denton
Dave Denton joined Pfizer as CFO and Executive Vice President effective May 2, 2022, providing strategic global financial leadership as a member of Pfizer's Executive Leadership Team. He oversees all financial operations and strategy for the company.
Dr. Chris Boshoff
Chris Boshoff, M.D., PhD, was appointed Chief Scientific Officer and President of Research & Development effective January 1, 2025, following a comprehensive selection process. Previously Chief Oncology Research and Development Officer, he leads Pfizer's global R&D efforts and scientific strategy.
Aamir Malik
Aamir Malik is Executive Vice President and Chief U.S. Commercial Officer, leading the U.S. Commercial business including Primary and Specialty Care Commercial and Medical Affairs, Oncology Commercial, Global Access and Value, and Global Chief Marketing Office organizations as a member of the Executive Leadership Team.
Dr. Andrew Baum
Andrew Baum, M.D., joined Pfizer as Chief Strategy and Innovation Officer and Executive Vice President, reporting to CEO Dr. Albert Bourla. He is a member of Pfizer's Executive Leadership Team responsible for corporate strategy and innovation initiatives.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Pfizer is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $63600M in revenue, Pfizer operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Pfizer with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Pfizer? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Pfizer Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pfizer vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →